Erschienen in:
01.04.2008 | Poster presentation
Short-term sevoflurane sedation using the anaesthetic conserving device AnaConDa® after cardiac surgery: feasibility, recovery and clinical issues
verfasst von:
KD Röhm, MW Wolf, J Boldt, T Schöllhorn, A Schellhaass, SN Piper
Erschienen in:
Critical Care
|
Sonderheft 2/2008
Einloggen, um Zugang zu erhalten
Excerpt
With the approval of the anaesthetic conserving device (AnaConDa
®), inhalative sedation in the ICU has become feasible [
1]. Isoflurane has been investigated in postoperative and critically ill patients using AnaConDa
®[
2,
3], whereas sevoflurane sedation has only been reported in small observations [
4,
5]. This randomised, single-blinded, BIS-controlled study was to evaluate for the first time sevoflurane via AnaConDa
® compared with propofol, with regard to recovery, sedation quality and consumption of anaesthetics. …